CH599191A5 - - Google Patents

Info

Publication number: CH599191A5
Authority: CH; Switzerland

Application number

CH318977A

Inventor

Roland Yves Mauvernay

Norbert Busch

Jacques Moleyre

Original Assignee

Cerm Cent Europ Rech Mauvernay

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-03-17

Filing date

1977-03-15

Publication date

1978-05-12

1977-03-15 Application filed by Cerm Cent Europ Rech Mauvernay filed Critical Cerm Cent Europ Rech Mauvernay

1978-05-12 Publication of CH599191A5 publication Critical patent/CH599191A5/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

CH318977A 1976-03-17 1977-03-15 CH599191A5 (xx)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR7607698A FR2344284A1 (fr)	1976-03-17	1976-03-17	Nouveaux composes tricycliques a cycle furannique et leur application comme antidepresseurs

Publications (1)

Publication Number	Publication Date
CH599191A5 true CH599191A5 (xx)	1978-05-12

Family

ID=9170573

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CH318977A CH599191A5 (xx)	1976-03-17	1977-03-15

Country Status (6)

Country	Link
US (1)	US4105785A (xx)
JP (1)	JPS52139054A (xx)
CH (1)	CH599191A5 (xx)
DE (1)	DE2710971A1 (xx)
FR (1)	FR2344284A1 (xx)
GB (1)	GB1522457A (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4255445A (en) *	1980-03-07	1981-03-10	Smithkline Corporation	8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
FR2493846A1 (fr) *	1980-11-10	1982-05-14	Delbarre B	Derives du 4h-benzo(4,5)cyclohepta(1,2-b)furanne, leur procede de preparation et leur application en tant que medicaments
US5244920A (en) *	1985-04-15	1993-09-14	Schering Spa	Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt
FR2613364B1 (fr) *	1987-04-01	1989-06-09	Adir	Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2739855B1 (fr) *	1995-10-13	1997-11-14	Adir	Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2002096374A2 (en)	2001-05-31	2002-12-05	Upsher-Smith Laboratories, Inc.	Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
SE0102299D0 (sv) *	2001-06-26	2001-06-26	Astrazeneca Ab	Compounds
SE0102764D0 (sv) *	2001-08-17	2001-08-17	Astrazeneca Ab	Compounds
GB0226930D0 (en)	2002-11-19	2002-12-24	Astrazeneca Ab	Chemical compounds
BRPI0507734A (pt) *	2004-02-18	2007-07-10	Astrazeneca Ab	composto ou um sal, pró-droga ou solvato do mesmo, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
WO2005080359A1 (en) *	2004-02-18	2005-09-01	Astrazeneca Ab	Benzamide derivatives and their use as glucokinae activating agents
TW200600086A (en) *	2004-06-05	2006-01-01	Astrazeneca Ab	Chemical compound
MX2007004560A (es)	2004-10-16	2007-06-08	Astrazeneca Ab	Proceso para hacer compuestos de fenoxi benzamida.
GB0423044D0 (en) *	2004-10-16	2004-11-17	Astrazeneca Ab	Compounds
GB0423043D0 (en) *	2004-10-16	2004-11-17	Astrazeneca Ab	Compounds
JP2008542247A (ja) *	2005-05-24	2008-11-27	アストラゼネカアクチボラグ	グルコキナーゼモジュレーターとしての２−フェニル置換イミダゾール［４，５ｂ］ピリジン／ピラジンおよびプリン誘導体
TW200714597A (en) *	2005-05-27	2007-04-16	Astrazeneca Ab	Chemical compounds
US20080234273A1 (en) *	2005-07-09	2008-09-25	Mckerrecher Darren	Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
US20110053910A1 (en) *	2005-07-09	2011-03-03	Mckerrecher Darren	2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
NZ575512A (en) *	2005-07-09	2009-11-27	Astrazeneca Ab	Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
US9202182B2 (en) *	2005-08-11	2015-12-01	International Business Machines Corporation	Method and system for analyzing business architecture
TW200738621A (en) *	2005-11-28	2007-10-16	Astrazeneca Ab	Chemical process
TW200825063A (en) *	2006-10-23	2008-06-16	Astrazeneca Ab	Chemical compounds
TW200825060A (en) *	2006-10-26	2008-06-16	Astrazeneca Ab	Chemical compounds
KR20090090390A (ko) *	2006-12-21	2009-08-25	아스트라제네카 아베	Ｇｌｋ 활성제로서 유용한 신규 결정 화합물
WO2010013240A1 (en)	2008-07-31	2010-02-04	Dekel Pharmaceuticals Ltd.	Compositions and methods for treating inflammatory disorders
CN102171213A (zh) *	2008-08-04	2011-08-31	阿斯利康(瑞典)有限公司	吡唑并[3，4]嘧啶-4-基衍生物及其治疗糖尿病和肥胖症的用途
GB0902434D0 (en) *	2009-02-13	2009-04-01	Astrazeneca Ab	Chemical process
GB0902406D0 (en) *	2009-02-13	2009-04-01	Astrazeneca Ab	Crystalline polymorphic form
AR076220A1 (es)	2009-04-09	2011-05-26	Astrazeneca Ab	Derivados de pirazol [4,5 - e] pirimidina
AR076221A1 (es) *	2009-04-09	2011-05-26	Astrazeneca Ab	Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL274885A (xx) *	1960-09-16
GB1074745A (en)	1963-07-29	1967-07-05	Sandoz Ltd	Benzo[4,5]cyclohepta[1,2-b]thiophene derivatives and their preparation

1976
- 1976-03-17 FR FR7607698A patent/FR2344284A1/fr active Granted
1977
- 1977-03-12 DE DE19772710971 patent/DE2710971A1/de not_active Withdrawn
- 1977-03-15 CH CH318977A patent/CH599191A5/xx not_active IP Right Cessation
- 1977-03-16 US US05/778,239 patent/US4105785A/en not_active Expired - Lifetime
- 1977-03-16 GB GB11200/77A patent/GB1522457A/en not_active Expired
- 1977-03-17 JP JP2974277A patent/JPS52139054A/ja active Pending

Also Published As

Publication number	Publication date
FR2344284B1 (xx)	1979-10-05
GB1522457A (en)	1978-08-23
JPS52139054A (en)	1977-11-19
DE2710971A1 (de)	1977-09-29
FR2344284A1 (fr)	1977-10-14
US4105785A (en)	1978-08-08

Publication	Publication Date	Title
FR2344284B1 (xx)	1979-10-05
JPS5744092B2 (xx)	1982-09-18
JPS54459B2 (xx)	1979-01-11
JPS5421844Y2 (xx)	1979-08-02
JPS5390416U (xx)	1978-07-24
JPS5369160U (xx)	1978-06-10
JPS52122804U (xx)	1977-09-19
JPS5255999Y2 (xx)	1977-12-17
JPS5638584Y2 (xx)	1981-09-09
JPS5353277U (xx)	1978-05-08
AU1283976A (xx)	1977-10-13
JPS5355555U (xx)	1978-05-12
CS178392B1 (xx)	1977-09-15
JPS5332049U (xx)	1978-03-20
JPS52122614U (xx)	1977-09-17
JPS52162937U (xx)	1977-12-10
JPS52124397U (xx)	1977-09-21
CH613611A5 (xx)	1979-10-15
CH611089A5 (xx)	1979-05-15
DD124001A1 (xx)	1977-02-02
DD123964A1 (xx)	1977-01-26
DD123795A1 (xx)	1977-01-19
DD123706A1 (xx)	1977-01-12
DD123698A1 (xx)	1977-01-12
DD123673A1 (xx)	1977-01-12

Legal Events

Date	Code	Title	Description
1981-11-30	PL	Patent ceased
2024-10-31	PL	Patent ceased